Explore the latest advances in biotechnology for treating hematological malignancies including menin inhibitors, protein degraders, and cutting-edge diagnostic tools.
Explore how CAR-T cell therapy is transforming hematological malignancy treatment through engineered immune cells, current FDA-approved therapies, and future innovations.